West CA, Shaw S, Sasser JM, Fekete A, Alexander T, Cunningham MW Jr, Masilamani SM, Baylis C. Chronic vasodilation increases renal medullary PDE5A and ␣-ENaC through independent renin-angiotensin-aldosterone system pathways. via diet], enalapril (ENAL; angiotensin-converting enzyme inhibitor, 62.5 mg/l via water), or vehicle (CON). Mean arterial pressure (MAP) was reduced 7.4 Ϯ 0.5% with NIF, 6.33 Ϯ 0.5% with NIF ϩ SPR, 13.3 Ϯ 0.9% with NIF ϩ LOS, and 12.0 Ϯ 0.4% with ENAL vs. baseline MAP. Compared with CON (3.6 Ϯ 0.3%), plasma volume factored for body weight was increased by NIF (5.2 Ϯ 0.4%) treatment but not by NIF ϩ SPR (4.3 Ϯ 0.3%), NIF ϩ LOS (3.6 Ϯ 0.1%), or ENAL (4.0 Ϯ 0.3%). NIF increased PDE5A protein abundance in the renal inner medulla, and SPR did not prevent this increase (188 Ϯ 16 and 204 Ϯ 22% of CON, respectively). NIF increased the ␣-subunit of the epithelial sodium channel (␣-ENaC) protein in renal outer (365 Ϯ 44%) and inner (526 Ϯ 83%) medulla, and SPR prevented these changes. There was no change in either PDE5A or ␣-ENaC abundance vs. CON in rats treated with NIF ϩ LOS or ENAL. These data indicate that the PVE and renal medullary adaptations in response to chronic vasodilation result from RAAS signaling, with increases in PDE5A mediated through AT 1 receptor and ␣-ENaC through the MR.